1
|
Pereira-Caro G, Clifford MN, Polyviou T, Ludwig IA, Alfheeaid H, Moreno-Rojas JM, Garcia AL, Malkova D, Crozier A. Plasma pharmacokinetics of (poly)phenol metabolites and catabolites after ingestion of orange juice by endurance trained men. Free Radic Biol Med 2020; 160:784-795. [PMID: 32927016 DOI: 10.1016/j.freeradbiomed.2020.09.007] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/27/2020] [Revised: 08/27/2020] [Accepted: 09/04/2020] [Indexed: 01/14/2023]
Abstract
The health benefits of orange juice (OJ) consumption are attributed in part to the circulating flavanone phase II metabolites and their microbial-derived ring fission phenolic catabolites. The present study investigated these compounds in the bloodstream after acute intake of 500 mL of OJ. Plasma samples obtained at 0, 1, 2, 3, 4, 5, 6, 7, 8 and 24 h after OJ intake were analysed by HPLC-HR-MS. Eleven flavanone metabolites and 36 phenolic catabolites were identified and quantified in plasma. The main metabolites were hesperetin-3'-sulfate with a peak plasma concentration (Cmax) of 80 nmol/L, followed by hesperetin-7-glucuronide (Cmax 24 nmol/L), hesperetin-3'-glucuronide (Cmax 18 nmol/L) and naringenin-7-glucuronide (Cmax 21 nmol/L). Among the main phenolic catabolites to increase in plasma after OJ consumption were 3'-methoxycinnamic acid-4'-sulfate (Cmax 19 nmol/L), 3-hydroxy-3-(3'-hydroxy-4'-methoxyphenyl)propanoic acid (Cmax 20 nmol/L), 3-(3'-hydroxy-4'-methoxyphenyl)propanoic acid (Cmax 19 nmol/L), 3-(4'-hydroxyphenyl)propanoic acid (Cmax 25 nmol/L), and 3-(phenyl)propanoic acid (Cmax 19 nmol/L), as well as substantial amounts of phenylacetic and hippuric acids. The comprehensive plasma pharmacokinetic profiles that were obtained are of value to the design of future ex vivo cell studies, aimed at elucidating the mechanisms underlying the potential health benefits of OJ consumption. CLINICAL TRIAL REGISTRATION NUMBER: This trial was registered at clinicaltrials.gov as NCT02627547.
Collapse
Affiliation(s)
- Gema Pereira-Caro
- Department of Food and Health, Andalusian Institute of Agricultural and Fishery Research and Training, IFAPA, Alameda Del Obispo, 14004, Córdoba, Spain.
| | - Michael N Clifford
- School of Bioscience and Medicine, Faculty of Health and Medical Sciences University of Surrey, Guildford, GU2 5XH, United Kingdom; Department of Nutrition, Dietetics and Food, Monash University, Notting Hill, VIC, 3168, Australia
| | - Thelma Polyviou
- Human Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow, G31 2ER, UK
| | - Iziar A Ludwig
- Medicinal Chemistry Laboratory, Center for Applied Medicinal Research, University of Navarra, Avda. Pío XII 55, E-31008, Pamplona, Spain
| | - Hani Alfheeaid
- Department of Food Science and Human Nutrition, College of Agriculture and Veterinary Medicine, Qassim University, Saudi Arabia
| | - José Manuel Moreno-Rojas
- Department of Food and Health, Andalusian Institute of Agricultural and Fishery Research and Training, IFAPA, Alameda Del Obispo, 14004, Córdoba, Spain
| | - Ada L Garcia
- Human Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow, G31 2ER, UK
| | - Dalia Malkova
- Human Nutrition, New Lister Building, University of Glasgow, Glasgow Royal Infirmary, 10-16 Alexandra Parade, Glasgow, G31 2ER, UK
| | - Alan Crozier
- School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, G12 8QQ, UK; United Kingdom and Department of Nutrition, University of California, Davis, CA, 95616, USA
| |
Collapse
|